Theralink Technologies, Inc. (THER)
- Previous Close
0.0013 - Open
0.0011 - Bid --
- Ask --
- Day's Range
0.0009 - 0.0011 - 52 Week Range
0.0007 - 0.0044 - Volume
2,300,006 - Avg. Volume
1,638,424 - Market Cap (intraday)
6.152M - Beta (5Y Monthly) 20.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date May 1, 2024 - May 5, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. In addition, the company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. The company was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies, Inc.is headquartered in Golden, Colorado.
www.theralink.comRecent News: THER
Performance Overview: THER
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: THER
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: THER
Valuation Measures
Market Cap
6.15M
Enterprise Value
29.88M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
9.68
Price/Book (mrq)
--
Enterprise Value/Revenue
47.03
Enterprise Value/EBITDA
4.73
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-191.54%
Return on Equity (ttm)
--
Revenue (ttm)
635.45k
Net Income Avi to Common (ttm)
-13.5M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
24.27k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-8.99M
Company Insights: THER
THER does not have Company Insights